Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanxi Weiqida Pharmaceutical is a leading Chinese pharmaceutical manufacturer specializing in antibiotic active pharmaceutical ingredients (APIs) and finished dosage forms. As a core subsidiary of the state-owned China Meheco Group, the company is one of the world's largest producers of clavulanate potassium and key antibiotic intermediates like 7-ACA and 6-APA. Its extensive product portfolio includes various penicillin and cephalosporin products, which are manufactured in large-scale, GMP-compliant facilities in Datong, Shanxi. The company serves both domestic and international markets, providing essential anti-infective treatments and raw materials to the global pharmaceutical industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanxi Weiqida Pharmaceutical.